Showing results (71-80 of 980) with videos related to
Sort By:
Pageof 98
Core Evidence|August 10, 2010
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndromeArash Aghel, W H Wilson TangClinical Science (London, England : 1979)|January 13, 2018
Gut microbiota in cardiovascular disease and heart failureTakeshi Kitai, W H Wilson TangDiabetes, Obesity & Metabolism|June 26, 2007
PPARgamma agonists: safety issues in heart failureW H Wilson Tang, Anjli MarooFaculty Reviews|January 14, 2022
Medical management of acute heart failureHayaan Kamran, W H Wilson TangCurrent Treatment Options in Cardiovascular Medicine|February 3, 2016
Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and IvabradineTakeshi Kitai, W H Wilson TangHospital Pharmacy|July 1, 1993
Impact of clozapine on medication use in a state hospitalD C Schalk, W H WilsonJournal of Pharmaceutical Sciences|April 1, 1995
Separation of basic drugs by packed-column supercritical fluid chromatography. 3. StimulantsT A Berger, W H WilsonCurrent Heart Failure Reports|May 25, 2023
Role of Sodium and Sodium Restriction in Heart FailurePieter Martens, W H Wilson TangHeart Failure Clinics|November 24, 2011
Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failureArvind Bhimaraj, W H Wilson TangPsychiatric Services (Washington, D.C.)|April 1, 1995
18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospitalW H Wilson, A M ClaussenPageof 98